Cargando…

CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS

Aging is associated with deficiency of Glutathione, the most abundant, intracellular, antioxidant protein, but underlying mechanisms are unknown and interventions limited. This symposium is primarily focused on the results of placebo-controlled, double-blind randomized clinical-trial (RCT) on the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekhar, Rajagopal, Taffet, George E, Fielding, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6840347/
http://dx.doi.org/10.1093/geroni/igz038.1550
_version_ 1783467605264171008
author Sekhar, Rajagopal
Taffet, George E
Fielding, Roger
author_facet Sekhar, Rajagopal
Taffet, George E
Fielding, Roger
author_sort Sekhar, Rajagopal
collection PubMed
description Aging is associated with deficiency of Glutathione, the most abundant, intracellular, antioxidant protein, but underlying mechanisms are unknown and interventions limited. This symposium is primarily focused on the results of placebo-controlled, double-blind randomized clinical-trial (RCT) on the impact of correcting Glutathione deficiency in older humans on mitochondrial impairment, oxidative stress, strength, inflammation, and insulin resistance. Dr. Jahoor’s presentation will serve as an introduction by discussing mechanisms underlying Glutathione deficiency and validation of a novel nutritional intervention based on supplementing glycine and N-acetylcysteine (GlyNAC) to correct Glutathione deficiency in older-humans. Dr. Sekhar will present the results of a pilot 16-week pilot randomized, placebo-controlled, double-blind clinical trial in older humans investigating the effect of supplementing GlyNAC (vs. placebo) to improve Glutathione levels and oxidative-stress in 24 older-humans and 12 young-humans on impaired mitochondrial fuel-oxidation (MFO) and other defects. The trial met its primary objective that that GlyNAC supplementation (and not placebo) significantly improved Glutathione deficiency and corrected impaired MFO (and defects in its molecular regulation), and also significantly improved gait-speed (increased 19% increase to match young-humans), muscle-strength, exercise-capacity, and lowered oxidative-stress (80%) inflammation (IL-6 83%, TNF-alpha 58%), and insulin-resistance (68%). Dr. Taffet will discuss age-induced diastolic heart failure, and the effect of supplementing GlyNAC (vs. NAC alone) in aged 24-month old mice with diastolic heart-failure, impaired myocardial MFO and cardiac-inflammation. Collectively this symposium on Glutathione and Aging will highlight the discovery that supplementing GlyNAC to correct Glutathione deficiency in older-humans has significant health benefits, and could be a novel nutritional-intervention in aging.
format Online
Article
Text
id pubmed-6840347
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68403472019-11-14 CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS Sekhar, Rajagopal Taffet, George E Fielding, Roger Innov Aging Session 2190 (Symposium) Aging is associated with deficiency of Glutathione, the most abundant, intracellular, antioxidant protein, but underlying mechanisms are unknown and interventions limited. This symposium is primarily focused on the results of placebo-controlled, double-blind randomized clinical-trial (RCT) on the impact of correcting Glutathione deficiency in older humans on mitochondrial impairment, oxidative stress, strength, inflammation, and insulin resistance. Dr. Jahoor’s presentation will serve as an introduction by discussing mechanisms underlying Glutathione deficiency and validation of a novel nutritional intervention based on supplementing glycine and N-acetylcysteine (GlyNAC) to correct Glutathione deficiency in older-humans. Dr. Sekhar will present the results of a pilot 16-week pilot randomized, placebo-controlled, double-blind clinical trial in older humans investigating the effect of supplementing GlyNAC (vs. placebo) to improve Glutathione levels and oxidative-stress in 24 older-humans and 12 young-humans on impaired mitochondrial fuel-oxidation (MFO) and other defects. The trial met its primary objective that that GlyNAC supplementation (and not placebo) significantly improved Glutathione deficiency and corrected impaired MFO (and defects in its molecular regulation), and also significantly improved gait-speed (increased 19% increase to match young-humans), muscle-strength, exercise-capacity, and lowered oxidative-stress (80%) inflammation (IL-6 83%, TNF-alpha 58%), and insulin-resistance (68%). Dr. Taffet will discuss age-induced diastolic heart failure, and the effect of supplementing GlyNAC (vs. NAC alone) in aged 24-month old mice with diastolic heart-failure, impaired myocardial MFO and cardiac-inflammation. Collectively this symposium on Glutathione and Aging will highlight the discovery that supplementing GlyNAC to correct Glutathione deficiency in older-humans has significant health benefits, and could be a novel nutritional-intervention in aging. Oxford University Press 2019-11-08 /pmc/articles/PMC6840347/ http://dx.doi.org/10.1093/geroni/igz038.1550 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Session 2190 (Symposium)
Sekhar, Rajagopal
Taffet, George E
Fielding, Roger
CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS
title CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS
title_full CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS
title_fullStr CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS
title_full_unstemmed CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS
title_short CORRECTING GLUTATHIONE DEFICIENCY IN AGING: IMPACT ON MITOCHONDRIA, STRENGTH, INFLAMMATION AND METABOLIC DEFECTS
title_sort correcting glutathione deficiency in aging: impact on mitochondria, strength, inflammation and metabolic defects
topic Session 2190 (Symposium)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6840347/
http://dx.doi.org/10.1093/geroni/igz038.1550
work_keys_str_mv AT sekharrajagopal correctingglutathionedeficiencyinagingimpactonmitochondriastrengthinflammationandmetabolicdefects
AT taffetgeorgee correctingglutathionedeficiencyinagingimpactonmitochondriastrengthinflammationandmetabolicdefects
AT fieldingroger correctingglutathionedeficiencyinagingimpactonmitochondriastrengthinflammationandmetabolicdefects